Your browser doesn't support javascript.
COVID-19 Screening of Breast Cancer Patients During Treatment: A Single Center Experience in Japan.
Yoshimoto, Nobuyasu; Takayama, Satoru; Sakamoto, Masaki; Ishikawa, Ken; Katada, Takeyasu; Kawate, Akifumi; Takura, Kohei; Takayama, Shoryu; Yamashita, Masakatsu; Yamamoto, Shinya; Yokoyama, Kioto; Kani, Hisanori.
  • Yoshimoto N; Department of Breast Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
  • Takayama S; Department of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
  • Sakamoto M; Department of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
  • Ishikawa K; Department of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
  • Katada T; Department of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
  • Kawate A; Department of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
  • Takura K; Department of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
  • Takayama S; Department of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
  • Yamashita M; Department of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
  • Yamamoto S; Department of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
  • Yokoyama K; Department of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
  • Kani H; Department of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Cancer Diagn Progn ; 1(5): 423-425, 2021.
Article in English | MEDLINE | ID: covidwho-1786540
ABSTRACT
Background/

Aim:

Breast cancer treatment mainly involves interventional methods such as surgical resection and chemotherapy. How to best perform these treatments during the COVID-19 pandemic remains to be established. Patients and

Methods:

Patients with breast cancer who received SARS-CoV-2 PCR screening before cancer treatment from December 2020 to April 2021 were included. PCR screening was performed within 72 hours of the scheduled admission time and treatment.

Results:

A total of 19 tests in 15 patients were analysed. Fourteen cases displayed no symptoms, and five cases had some symptoms. COVID PCR tests were negative in all cases.

Conclusion:

COVID-19 screening can ensure that breast cancer patients do not miss scheduled treatments as a result of the pandemic. Diagnosis of patients with symptoms that are shared by COVID-19 infection, chemotherapy, and breast cancer recurrence must be performed carefully.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study Language: English Journal: Cancer Diagn Progn Year: 2021 Document Type: Article Affiliation country: Cdp.10056

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study Language: English Journal: Cancer Diagn Progn Year: 2021 Document Type: Article Affiliation country: Cdp.10056